bpc-157 benefits risks research FDA's Review Of Peptides Signals A Growing Public Health Challenge Hot-button peptides like BPC-157 and

There is no known tolerance buildup, and side effects dont increase with longer use

And another 5-alpha reductase inhibiting drug Dutasteride seems to do the same thing (using a slightly different molecule)

It is a narrower argument: that this compound, sold this way, now , is running a long way ahead of its evidence, and that the confusion between the two molecules is much of what makes that possible

In a study published in The Journal of Clinical Endocrinology & Metabolism , Tesamorelin elevated IGF-1 levels within 2 weeks of administration, confirming its efficacy in stimulating GH pathways (Gelato et al., 2004)

[PubMed: 9886807] 64

Chapter 39, Lindsay H